Gliomas with IDH1 mutations can be sub-classified into two types: those with 1p/19q co-deletion, known as ODs, and those with intact 1p/19q, identified as astrocytomas, leading to better OS in patients with OD [2]. Here, IDH1 is linked to central nervous system cancer.